A DUAL MTOR/NAD+ ACTING GEROTHERAPY

The geroscience hypothesis states that a therapy that prevents the underlying aging process should prevent multiple aging related diseases. The mTOR (mechanistic target of rapamycin)/insulin and NAD+ (nicotinamide adenine dinucleotide) pathways are two of the most validated aging pathways. Yet, it’s...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jinmei, Kumar, Sandeep, Miachin, Kirill, Bean, Nicholas L., Halawi, Ornella, Lee, Scott, Park, JiWoong, Pierre, Tanya H., Hor, Jin-Hui, Ng, Shi-Yan, Wallace, Kelvin J., Rindtorff, Niklas, Miller, Timothy M., Niehoff, Michael L., Farr, Susan A., Kletzien, Rolf F., Colca, Jerry, Tanis, Steven P., Chen, Yana, Griffett, Kristine, McCommis, Kyle S., Finck, Brian N., Peterson, Tim R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9882180/
https://www.ncbi.nlm.nih.gov/pubmed/36711589
http://dx.doi.org/10.1101/2023.01.16.523975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9882180/
https://www.ncbi.nlm.nih.gov/pubmed/36711589
http://dx.doi.org/10.1101/2023.01.16.523975

Ejemplares similares